Target intelligence / Profile preview

RNA, U6 small nuclear 322, pseudogene (RNU6-322P)

Target
RNU6-322P
Molecular classification
Other (Pseudogene, Small nuclear RNA)
01

Overview

RNA, U6 small nuclear 322, pseudogene (RNU6-322P), is a member of a large family of U6 small nuclear RNA (snRNA) pseudogenes found throughout vertebrate genomes[3][2]. Pseudogenes like RNU6-322P are non-functional, typically generated by retrotransposition events involving the active parental U6 snRNA gene, and do not produce functional RNA or protein products[3]. Functional U6 snRNA molecules are essential components of the spliceosomal complex, driving the removal of introns from pre-mRNA and playing a central structural and catalytic role in the spliceosome[1][2]. However, pseudogenes such as RNU6-322P lack this function; they serve primarily as genomic markers for retrotransposition activity and have no established direct biological or disease relevance[3][2]. They are not considered therapeutic targets, nor are they involved in known drug interactions or clinical biomarker strategies. Their presence is primarily of interest in evolutionary, genomic, or retrotransposon biology studies rather than molecular pharmacology or therapeutics[3][2].

Other names
RNU6-322PU6 snRNA pseudogene 322

Beyond the preview

Go deeper on RNA, U6 small nuclear 322, pseudogene (RNU6-322P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 322, pseudogene (RNU6-322P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call